长江商报记者注意到，作为传统的金属结构件供应商，科森科技近年来拓展医疗、储能领域，丰富业务结构。其 中，科森医疗主要经营微创手术器械产品的加工与出口业务。 然而，受外部市场环境变迁与影响，科森医疗的业务发展面临挑战。同时，科森医疗的技术路径与客户群体均与 科森科技的核心主业存在差异，协同效应有限。因此，科森科技决定通过此笔资产出售，退出医疗业务，改善现 金流。 数据显示，2023年至2025年前9个月，科森科技持续亏损，归属于上市公司股东的净利润(以下简称"归母净利润") 累计亏损8.73亿元。 截至2025年9月末，科森科技资产总额51.2亿元，资产负债率58.34%，期末公司应收账款规模仍高达11.74亿元。 科森科技初步计算，本次交易预计将增加公司2025年度投资收益约6亿元(计入非经常性损益)。 拟9.15亿出售科森医疗100%股权 根据出售计划，科森科技将其持有的科森医疗100%的股权转让给江苏耀岭科医疗科技有限公司(以下简称"耀岭 科")。本次交易完成后，上市公司将不再持有科森医疗股权，科森医疗不再纳入上市公司的合并报表范围。 业绩持续承压，科森科技（603626）(603626.SH)通过"瘦身 ...

于本联合公布日期，Surearn Profits仅持有华力达全部已发行股本的50%的法定及实益权益，而华力达则 持有该物业以及与该物业相关的资产及负债的全部法定及实益权益。卖方应促使清盘并将该物业按华力 达的持股比例进行分派。卖方于该物业的50%权益指SPL物业。于上述分派后及于完成前，SPL物业及 华力达的其他资产包括租户支付的按金及就SPL物业支付予物业经理的按金，将分派及转让予Surearn Profits。于完成后，卖方将不再持有SPL物业或Surearn Profits的任何权益。 代价应为协定物业价值(即34.98亿港元)与根据买卖协议厘定的完成时Surearn Profits流动资产净值之和。 所得款项预期将透过增加现金流入及减少贷款，巩固丽新制衣集团及丽新发展集团的财务状况，其中估 计净现金流入约为24亿港元。于2025年7月31日，丽新制衣集团及丽新发展集团的流动负债净额分别为 54.2亿港元及45.06亿港元。考虑到长沙湾广场银团贷款于2025年9月30日在丽新发展集团层面成功再融 资，并假设出售事项经已完成，丽新制衣集团及丽新发展集团均将由流动负债净额转为流动资产净额。 丽新国际(001 ...

于本联合公布日期，Surearn Profits仅持有华力达全部已发行股本的50%的法定及实益权益，而华力达则 持有该物业以及与该物业相关的资产及负债的全部法定及实益权益。卖方应促使清盘并将该物业按华力 达的持股比例进行分派。卖方于该物业的50%权益指SPL物业。于上述分派后及于完成前，SPL物业及 华力达的其他资产包括租户支付的按金及就SPL物业支付予物业经理的按金，将分派及转让予Surearn Profits。于完成后，卖方将不再持有SPL物业或Surearn Profits的任何权益。 代价应为协定物业价值(即34.98亿港元)与根据买卖协议厘定的完成时Surearn Profits流动资产净值之和。 所得款项预期将透过增加现金流入及减少贷款，巩固丽新制衣集团及丽新发展集团的财务状况，其中估 计净现金流入约为24亿港元。于2025年7月31日，丽新制衣集团及丽新发展集团的流动负债净额分别为 54.2亿港元及45.06亿港元。考虑到长沙湾广场银团贷款于2025年9月30日在丽新发展集团层面成功再融 资，并假设出售事项经已完成，丽新制衣集团及丽新发展集团均将由流动负债净额转为流动资产净额。 智通财经APP讯 ...

二级市场方面，截至发稿，中国中冶A股开盘下挫，逼近跌停，港股下跌超20% | Ａ股 | | | | 港股 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 3.06元 -0.33 -9.73% | | | | | | | | | 交易中 12-09 10:13:00 北京时间 | | | | | | | | | 今开 | 3.23 | | 最高 | 3.23 | | 成交量 | 500.18万手 | | 昨收 | 3.39 | | 最低 | 3.05 | | 成交额 | 15.44亿 | | 换手率 | 2.80% | | 市盈(TTM) | 16.32 | | 总市值 | 634.14亿 | | 分时 | 王日 | 日K | 周K | 月K | 季K | 年K | 亜多い | | 3.23 | | | | | | | -4.72% | | 14 | | | | | | | -7.38% | | | | | | | | | -10.03% | 12月8日晚间，中国中冶（SH601618，股价3.39元，市值702.53亿元）发布公告称，拟将 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、已披露的拟对外出售资产暨关联交易概述 芯联集成电路制造股份有限公司（以下简称"公司"、"芯联集成"）在芯片实验室检测领域深耕数年，在 硬件设施、实验设备、软件、技术、资质、经验和人员等方面有了丰富的积累。为了更好的服务客户， 扩大检测收入，优化产品结构，公司控股子公司芯联先锋集成电路制造（绍兴）有限公司（以下简 称"芯联先锋"）与临港新片区基金设立合资公司上海芯港联测半导体有限责任公司（以下简称"芯港联 测"、"受让方"）。合资公司注册资本人民币40,000.00万元，芯联先锋使用自有资金出资人民币 20,000.00万元，占注册资本总额50.00%。为快速推动项目的建设，实现合资公司业务的独立开展，公 司及公司子公司将持有的检测业务设备、专利及非专利型专有技术转让给芯港联测。公司于2025年9月 12日、2025年9月29日分别召开第二届董事会第八次会议和2025年第二次临时股东大会，审议通过了 《关于拟对外出售资产暨关联交易的议案》。具体内容详见公司于2025年9月1 ...

作为央企内部资源整合，这笔交易买方均为中国中冶的控股股东中国五矿集团有限公司(以下简称中国五矿)及其关联方。 二级市场方面，截至发稿，中国中冶A股开盘下挫，逼近跌停，港股下跌超20% | Ａ股 | | | | 港股 | | | | --- | --- | --- | --- | --- | --- | --- | | 3.06元 -0.33 -9.73% | | | | | | | | 交易中 12-09 10:13:00 北京时间 | | | | | | | | 今开 | 3.23 | 最高 | 3.23 | | 成交量 | 500.18万手 | | 昨收 | 3.39 | 最低 | 3.05 | | 成交额 | 15.44亿 | | 换手率 | 2.80% | 市盈(TTM) | 16.32 | | 总市值 | 634.14亿 | | 分时 日K | 王日 | 周K | 月K | 塾K | 年K | 亜多い | | 3.23 | | | | | | -4.72% | | 14 | | | | | | -7.38% | | | | | | | | -10.03% | | A股 | | | | | 港股 | ...

截至12月8日收盘，中国中冶股价为3.39元，市值为667亿元。 12月8日晚，中国中冶公告(601618.SH)称，公司拟将所持有的中冶置业100%股权及对中冶置业的标的 债权，有色院、中冶铜锌、瑞木管理100%股权，中冶金吉67.02%股权，以及华冶杜达100%股权出售给 五矿地产控股和中国五矿，交易价格为606.76亿元。本次交易构成关联交易，不构成重大资产重组，已 达到股东会审议标准，需提交股东会审议批准。 0:00 ...

Core Viewpoint - Far East Development announced the sale of its stake in the Ritz-Carlton hotel operations and property company in Perth, Australia, for a total consideration of AUD 100 million (approximately HKD 515 million) to The Generation Essentials Group (NYSE: TGE) [2] Group 1 - The transaction aims to realize the value of the hotel, facilitate capital recycling, enhance the group's liquidity, and optimize its net asset-liability ratio [2] - The board believes that this sale aligns with the group's strategy to release profits from its hotel portfolio and divest non-core assets [2]

Major Events - GuoXia Technology (02655) plans to conduct an IPO from December 8 to December 11, offering 33.85 million H-shares and introducing cornerstone investors such as Huikai Hong Kong [1] - Basilea Pharmaceutica AG (02616) has its drug Pujihua® (Pralsetinib Capsules) included in the National Medical Insurance Directory for 2025 [1] - Four Seasons Pharmaceutical (00460) sees its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Shanghai Pharmaceuticals (02607) successfully negotiates and includes Amisulpride Orally Disintegrating Tablets in the National Medical Insurance Directory [1] - Hansoh Pharmaceutical (03692) has its innovative drug Amelotex® approved for two new indications in the updated 2025 National Medical Insurance Directory [1] - Xiansheng Pharmaceutical (02096) sees EnzeShu® and EnDu® included in the updated National Medical Insurance Drug List [1] - Hutchison China MediTech (00013) has its drug Tazverik® included in the first edition of the National Commercial Health Insurance Innovative Drug List [1] - XuanZhu Biotechnology (02575) has its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Yino Pharmaceutical (02591) has its H-shares included in the list of eligible securities for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect [1] - China Metallurgical Group (01618) and its subsidiaries plan to sell non-core business assets for approximately 60.68 billion yuan, focusing on core businesses in metallurgical engineering, non-ferrous metals, and mining engineering [1] - Cambridge Technology (06166) intends to invest a total of 405 million yuan to acquire and subscribe for shares in the Yangzhong Happiness Home Venture Capital Partnership Fund [1] Operating Performance - Dongfeng Motor Group (00489) reports cumulative automobile sales of 1.697 million units in the first 11 months, a year-on-year decrease of approximately 0.3% [2] - New天绿色能源 (00956) achieves a cumulative power generation of 1,336.89 million MWh in the first 11 months, an increase of 8.04% year-on-year [2] - Longyuan Power (00916) reports a cumulative power generation of approximately 6,909.64 million MWh in the first 11 months, a year-on-year growth of 0.41% [2] - Baolong Real Estate (01238) records a total contract sales of approximately 6.666 billion yuan in the first 11 months, a year-on-year decline of 43.2% [2]

Group 1 - The company announced a conditional sale agreement with The Generation Essentials Group for the sale of 50% of shares in two subsidiaries, RC Perth Operations Pty Ltd and Perth FEC Pty Ltd, for a total consideration of AUD 100 million (approximately HKD 515 million) [1] - The subsidiaries involved include an operational company primarily engaged in investment holding and a property company focused on property investment, both of which are wholly owned by the company [1] - The hotel in question is the Ritz-Carlton located at 1 Barrack St, Perth WA 6000, Australia [1] Group 2 - The board believes that the transaction will realize the value of the hotel, enable the reinvestment of proceeds, increase liquidity, and reduce the company's net asset liability ratio [2] - The transaction aligns with the company's strategy to release profits from its hotel portfolio and divest non-core assets [2]